BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2409275)

  • 41. Molecular biology of Entamoeba histolytica: a review.
    Carrero JC; Laclette JP
    Arch Med Res; 1996; 27(3):403-12. PubMed ID: 8854402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serologic response to the 96,000-Da surface antigen of pathogenic Entamoeba histolytica.
    Torian BE; Reed SL; Flores BM; Plorde J; Stamm WE
    J Infect Dis; 1989 Apr; 159(4):794-7. PubMed ID: 2538522
    [No Abstract]   [Full Text] [Related]  

  • 43. Cell biological analysis of parasite-host cell interactions. II. Cell surface, phagocytosis and virulence of Entamoeba histolytica, a review.
    Bos HJ
    Acta Leiden; 1979; 47():23-35. PubMed ID: 233565
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunologic studies on hamsters infected with Entamoeba histolytica.
    Gold D; Norman LG; Maddison SE; Kagan IG
    J Parasitol; 1978 Oct; 64(5):866-73. PubMed ID: 214539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility of various strains of mice to Entamoeba histolytica.
    Gold D; Kagan IG
    J Parasitol; 1978 Oct; 64(5):937-8. PubMed ID: 214540
    [No Abstract]   [Full Text] [Related]  

  • 46. Molecular changes in Entamoeba histolytica in response to bacteria.
    Bhattacharya A; Anand MT; Paul J; Yadav N; Bhattacharya S
    J Eukaryot Microbiol; 1998; 45(2):28S-33S. PubMed ID: 9561781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Translation of RNA obtained from Entamoeba histolytica and its characterization of a specific monoclonal antibody].
    Mendoza F; Ximénez C; Díaz de León L; Ortiz Ortiz L
    Salud Publica Mex; 1985; 27(3):241-5. PubMed ID: 2413554
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative evaluation of hexokinase isoenzyme typing and antigen detection for differentiation of Entamoeba histolytica and Entamoeba dispar.
    Bansal D; Sehgal R; Chawla Y; Mahajan RC; Malla N
    Nepal Med Coll J; 2004 Dec; 6(2):123-5. PubMed ID: 16295743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyruvate: ferredoxin oxidoreductase from Entamoeba histolytica recognized by a monoclonal antibody.
    Thammapalerd N; Kotimanusvanij D; Duchêne M; Upcroft JA; Mitchell R; Healey A; Samarawickrema N; Tharavanij S; Wiedermann G; Upcroft P
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):63-70. PubMed ID: 9031403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Entamoeba histolytica].
    Kobayashi S
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():288-91. PubMed ID: 20942060
    [No Abstract]   [Full Text] [Related]  

  • 51. Determination of the prevalence of Entamoeba histolytica and E. dispar in the pernambuco state of northeastern Brazil by a polymerase chain reaction.
    Pinheiro SM; Carneiro RM; Aca IS; Irmão JI; Morais MA; Coimbra MR; Carvalho LB
    Am J Trop Med Hyg; 2004 Feb; 70(2):221-4. PubMed ID: 14993636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of intestinal ameobiasis in patients with diarrhea by adhesin antigen test and direct microscopy].
    Yıldırım D; Hasbek M; Nur N
    Turkiye Parazitol Derg; 2014; 38(3):155-8. PubMed ID: 25308451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An immunogenic 30-kDa surface antigen of pathogenic clinical isolates of Entamoeba histolytica.
    Blakely P; Sargeaunt PG; Reed SL
    J Infect Dis; 1990 Oct; 162(4):949-54. PubMed ID: 2205653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primates as a source of Entamoeba histolytica, their zymodeme status and zoonotic potential.
    Smith JM; Meerovitch E
    J Parasitol; 1985 Dec; 71(6):751-6. PubMed ID: 2869116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intestinal invasion by Entamoeba histolytica.
    Solaymani-Mohammadi S; Petri WA
    Subcell Biochem; 2008; 47():221-32. PubMed ID: 18512355
    [No Abstract]   [Full Text] [Related]  

  • 56. Development of monoclonal antibodies specifically recognizing the cyst stage of Entamoeba histolytica.
    Walderich B; Burchard GD; Knobloch J; Müller L
    Am J Trop Med Hyg; 1998 Sep; 59(3):347-51. PubMed ID: 9749623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of monoclonal antibodies directed against cysts of Entamoeba histolytica and Entamoeba dispar.
    Walderich B; Müller L; Knobloch J; Burchard GD
    Arch Med Res; 1997; 28 Spec No():147-9. PubMed ID: 9033048
    [No Abstract]   [Full Text] [Related]  

  • 58. Entamoeba histolytica: pathogenic mechanisms, human immune response, and vaccine development.
    Ravdin JI
    Clin Res; 1990 Apr; 38(2):215-25. PubMed ID: 2186887
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of cellular immunity on the interaction between the peritoneal cell and the ameba in vitro].
    Pérez-Tamayo R; Martínez-Villegas JE; Pérez-Montfort R
    Arch Invest Med (Mex); 1986; 17 Suppl 1():259-67. PubMed ID: 2884966
    [No Abstract]   [Full Text] [Related]  

  • 60. Studies of the antigenic activity of Entamoeba histolytica extracts.
    Kochanowska E; Myjak P; Pietkiewicz H
    Bull Inst Marit Trop Med Gdynia; 1986; 37(1-2):43-56. PubMed ID: 2884001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.